ZA939665B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA939665B
ZA939665B ZA939665A ZA939665A ZA939665B ZA 939665 B ZA939665 B ZA 939665B ZA 939665 A ZA939665 A ZA 939665A ZA 939665 A ZA939665 A ZA 939665A ZA 939665 B ZA939665 B ZA 939665B
Authority
ZA
South Africa
Prior art keywords
pct
hydrogen
date jul
represent
sec
Prior art date
Application number
ZA939665A
Other languages
English (en)
Inventor
Edward Andrew Boyd
Brenda Costall
Mary Elizabeth Kelly
Philip James Parsons
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA939665B publication Critical patent/ZA939665B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA939665A 1992-12-23 1993-12-23 Pharmaceutical compositions ZA939665B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226857A GB9226857D0 (en) 1992-12-23 1992-12-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA939665B true ZA939665B (en) 1995-06-23

Family

ID=10727141

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939665A ZA939665B (en) 1992-12-23 1993-12-23 Pharmaceutical compositions

Country Status (15)

Country Link
US (1) US5707988A (ko)
EP (1) EP0675890B1 (ko)
JP (1) JP3542803B2 (ko)
KR (1) KR100320996B1 (ko)
AT (1) ATE151427T1 (ko)
AU (1) AU680645B2 (ko)
CA (1) CA2152284C (ko)
DE (1) DE69309714T2 (ko)
DK (1) DK0675890T3 (ko)
ES (1) ES2101483T3 (ko)
GB (2) GB9226857D0 (ko)
GR (1) GR3023744T3 (ko)
IL (1) IL108135A (ko)
WO (1) WO1994014816A1 (ko)
ZA (1) ZA939665B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313628D0 (en) * 2003-06-12 2003-07-16 Btg Int Ltd Psychoactive compounds
EP1631557B1 (en) * 2003-06-12 2006-12-20 Btg International Limited Cyclic hydroxylamine as psychoactive compounds
TW201020233A (en) * 2008-10-09 2010-06-01 Kyorin Seiyaku Kk Isoquinoline derivative, and pde inhibitor comprising same as active ingredient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1540580A (en) * 1975-09-02 1979-02-14 Shell Int Research Fungicidal isoxazolidines
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
JP3042876B2 (ja) * 1989-05-24 2000-05-22 バイオサーフイス・フアーマ・アクチエボラーグ 置換されたイソキサゾリジンおよびイソキサゾリン
US5114936A (en) * 1990-08-23 1992-05-19 Hoechst-Roussel Pharmaceuticals Incorporated 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives

Also Published As

Publication number Publication date
JP3542803B2 (ja) 2004-07-14
GB9226857D0 (en) 1993-02-17
CA2152284C (en) 2006-01-17
DE69309714D1 (de) 1997-05-15
AU680645B2 (en) 1997-08-07
GR3023744T3 (en) 1997-09-30
GB2273706B (en) 1996-06-05
KR960700249A (ko) 1996-01-19
GB2273706A (en) 1994-06-29
IL108135A0 (en) 1994-08-26
ATE151427T1 (de) 1997-04-15
EP0675890A1 (en) 1995-10-11
DK0675890T3 (da) 1997-05-05
IL108135A (en) 1998-04-05
ES2101483T3 (es) 1997-07-01
JPH08504796A (ja) 1996-05-21
DE69309714T2 (de) 1997-08-21
US5707988A (en) 1998-01-13
CA2152284A1 (en) 1994-07-07
WO1994014816A1 (en) 1994-07-07
KR100320996B1 (ko) 2002-07-27
AU5573394A (en) 1994-07-19
EP0675890B1 (en) 1997-04-09
GB9325044D0 (en) 1994-02-02

Similar Documents

Publication Publication Date Title
ATE164837T1 (de) Acetamidderivate und ihre verwendung als modifizierungsmittel des verhaltens der verdauung
DE69116815D1 (de) Erythromycinderivate, ihre Verfahren zur Herstellung, Zwischenprodukte und ihre Anwendung als Medikamente
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
GB9226857D0 (en) Pharmaceutical compositions
DK0689534T3 (da) Amidderivater som 5-HT1A-ligander
DE59304311D1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
ATE148463T1 (de) N-acyl-substituierte azazyklische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69103271T2 (de) Benzothiazolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IL104771A0 (en) Hydroisoxazoles and pharmaceutical compositions containing them
ES2174077T3 (es) Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas.
DE59309487D1 (de) Isoxazolcarbonsäureamide, verfahren zu ihrer herstellung und ihre verwendung